fura-2 has been researched along with monocrotaline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, K; Honda, M; Ishinaga, Y; Kuramochi, T; Kuzuo, H; Morioka, S; Takabatake, T; Tanaka, K | 1 |
| Chen, GY; Hu, Y; Lin, MJ; Liu, Q; Liu, XR; Sham, JS | 1 |
| Chang, R; Cui, B; Fan, Z; Hiram, R; Huang, C; Huang, H; Liu, T; Shi, S; Su, X; Tang, Y; Wu, G; Wu, J; Xiong, F; Yan, M; Zhang, W | 1 |
1 trial(s) available for fura-2 and monocrotaline
| Article | Year |
|---|---|
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Calcium; Connexin 43; Disease Models, Animal; Fura-2; Glucose; Glucosides; Heart Failure; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Sodium; Ventricular Dysfunction, Right; Ventricular Remodeling | 2022 |
2 other study(ies) available for fura-2 and monocrotaline
| Article | Year |
|---|---|
Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Fura-2; Heart; Heart Failure; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Monocrotaline; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Sprague-Dawley | 1994 |
Down-regulation of TRPM8 in pulmonary arteries of pulmonary hypertensive rats.
Topics: Animals; Cations; Down-Regulation; Fura-2; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Manganese; Menthol; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; TRPM Cation Channels; Vasodilation | 2013 |